Susquehanna International Group, LLP Corvus Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1.78 - $5.92 $40,406 - $134,384	22,700 Added 152.35%	37,600 $198,000
Q2 2024 Aug 15, 2024	SELL	$1.36 - $2.29 $136 - $229	-100 Reduced 0.67%	14,900 $27,000
Q1 2024 May 07, 2024	BUY	$1.76 - $2.41 $2,816 - $3,856	1,600 Added 11.94%	15,000 $26,000
Q4 2023 Feb 14, 2024	SELL	$1.08 - $1.92 $3,672 - $6,528	-3,400 Reduced 20.24%	13,400 $23,000
Q3 2023 Nov 14, 2023	BUY	$1.41 - $2.97 $23,688 - $49,896	16,800 New	16,800 $24,000
Q2 2022 Aug 15, 2022	SELL	$0.87 - $2.03 $12,528 - $29,231	-14,400 Reduced 56.47%	11,100 $11,000
Q1 2022 May 16, 2022	SELL	$1.46 - $2.48 $56,648 - $96,224	-38,800 Reduced 60.34%	25,500 $42,000
Q4 2021 Feb 14, 2022	SELL	$2.34 - $5.31 $442,260 - $1 Million	-189,000 Reduced 74.62%	64,300 $155,000
Q3 2021 Nov 15, 2021	BUY	$1.89 - $8.53 $450,198 - $2.03 Million	238,200 Added 1577.48%	253,300 $1.23 Million
Q2 2021 Aug 11, 2021	SELL	$2.46 - $3.14 $117,588 - $150,092	-47,800 Reduced 75.99%	15,100 $40,000
Q4 2020 Feb 16, 2021	BUY	$3.56 - $4.86 $50,908 - $69,498	14,300 Added 29.42%	62,900 $224,000
Q3 2020 Nov 16, 2020	BUY	$2.6 - $5.37 $126,360 - $260,982	48,600 New	48,600 $195,000

30.4M

1.06M

84.3K

Ticker CRVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,553,500
Market Cap $223M
Description
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.